Menu

Filtros : "HIV Medicine" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico-carta/editorial

    Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial (2015)

    ; Casseb, Jorge Simão do Rosário

    Source: HIV Medicine. Unidade: IMT

    Subjects: HIV, TERAPIA ANTIRRETROVIRAL DE ALTA ATIVIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      , e CASSEB, Jorge Simão do Rosário. Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Medicine. Oxford: Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo. Disponível em: https://doi.org/10.1111/hiv.12227. Acesso em: 04 jun. 2024. , 2015

    • APA

      ,, & Casseb, J. S. do R. (2015). Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial. HIV Medicine. Oxford: Instituto de Medicina Tropical de São Paulo, Universidade de São Paulo. doi:10.1111/hiv.12227

    • NLM

      , Casseb JS do R. Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial [Internet]. HIV Medicine. 2015 ; 16 1-9.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/hiv.12227

    • Vancouver

      , Casseb JS do R. Why START?: Reflections that led to the conduct of this large long-term strategic HIV trial [Internet]. HIV Medicine. 2015 ; 16 1-9.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/hiv.12227

  • Artigo de periodico

    Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study (2014)

    Tudor-Williams, G.; Cahn, P.; Chokephaibulkit, K.; Fourie, J.; Karatzios, C.; Dincq, S.; Opsomer, M.; Nakuda, T. N.; Nijs, S.; Tambuyzer, L.; Tomaka, F. L.; Mussi-Pinhata, Marisa Márcia

    Source: HIV Medicine. Unidade: FMRP

    Subjects: PEDIATRIA, FARMACOCINÉTICA, ANTIVIRAIS, INFECÇÕES POR HIV

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      TUDOR-WILLIAMS, G. et al. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Medicine, v. 15, n. 9, p. 513-524, 2014Tradução . . Disponível em: https://doi.org/10.1111/hiv.12141. Acesso em: 04 jun. 2024.

    • APA

      Tudor-Williams, G., Cahn, P., Chokephaibulkit, K., Fourie, J., Karatzios, C., Dincq, S., et al. (2014). Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study. HIV Medicine, 15( 9), 513-524. doi:10.1111/hiv.12141

    • NLM

      Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Nakuda TN, Nijs S, Tambuyzer L, Tomaka FL, Mussi-Pinhata MM. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study [Internet]. HIV Medicine. 2014 ; 15( 9): 513-524.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/hiv.12141

    • Vancouver

      Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Nakuda TN, Nijs S, Tambuyzer L, Tomaka FL, Mussi-Pinhata MM. Etravirine in treatment-experienced, HIV-1-infected chidren and adolescents: 48-week safety, efficacy and resistance analysis of the phase II PIANO study [Internet]. HIV Medicine. 2014 ; 15( 9): 513-524.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1111/hiv.12141
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024